In last trading session, Onconetix Inc (NASDAQ:ONCO) saw 0.46 million shares changing hands with its beta currently measuring 3.17. Company’s recent per share price level of $0.40 trading at -$0.02 or -4.50% at ring of the bell on the day assigns it a market valuation of $5.84M. That closing price of ONCO’s stock is at a discount of -5250.0% from its 52-week high price of $21.40 and is indicating a premium of 20.0% from its 52-week low price of $0.32.

Onconetix Inc (NASDAQ:ONCO) trade information

Upright in the red during last session for losing -4.50%, in the last five days ONCO remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $0.40 price level, adding 28.57% to its value on the day. Onconetix Inc’s shares saw a change of -36.33% in year-to-date performance and have moved -26.05% in past 5-day. Onconetix Inc (NASDAQ:ONCO) showed a performance of -18.09% in past 30-days.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -116.38% during past 5 years.

On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 53.6 shares of worth $21497.0 or 0.37% of the total outstanding shares. The later fund manager was in possession of 1.84 shares on Sep 30, 2024 , making its stake of worth around $736.0 in the company or a holder of 0.01% of company’s stock.